vs
Citizens Community Bancorp Inc.(CZWI)与Foghorn Therapeutics Inc.(FHTX)财务数据对比。点击上方公司名可切换其他公司
Citizens Community Bancorp Inc.的季度营收约是Foghorn Therapeutics Inc.的1.7倍($15.8M vs $9.2M),Citizens Community Bancorp Inc.净利率更高(27.1% vs -234.3%,领先261.4%),Foghorn Therapeutics Inc.同比增速更快(223.8% vs 14.9%),过去两年Foghorn Therapeutics Inc.的营收复合增速更高(35.3% vs 1.9%)
冰川银行集团是一家总部位于美国蒙大拿州卡利斯佩尔的区域性多元化银行控股公司,最早前身企业于1990年完成注册。集团在美国蒙大拿、爱达荷、犹他、华盛顿、怀俄明、科罗拉多、亚利桑那及内华达共设有221个网点,为客户提供个人及商业银行服务。
Foghorn Therapeutics是一家临床阶段生物技术企业,专注于开发靶向染色质调控系统的创新疗法,用于治疗多种癌症及其他严重疾病,目前推进多款靶向候选药物管线,通过自主研发与战略合作服务全球患者群体。
CZWI vs FHTX — 直观对比
营收规模更大
CZWI
是对方的1.7倍
$9.2M
营收增速更快
FHTX
高出208.9%
14.9%
净利率更高
CZWI
高出261.4%
-234.3%
两年增速更快
FHTX
近两年复合增速
1.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $15.8M | $9.2M |
| 净利润 | $4.3M | $-21.7M |
| 毛利率 | — | — |
| 营业利润率 | 31.0% | -258.2% |
| 净利率 | 27.1% | -234.3% |
| 营收同比 | 14.9% | 223.8% |
| 净利润同比 | 58.1% | -11.1% |
| 每股收益(稀释后) | $0.44 | $-0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CZWI
FHTX
| Q4 25 | $15.8M | $9.2M | ||
| Q3 25 | $16.2M | $8.2M | ||
| Q2 25 | $16.1M | $7.6M | ||
| Q1 25 | $14.2M | $6.0M | ||
| Q4 24 | $13.7M | $2.9M | ||
| Q3 24 | $14.2M | $7.8M | ||
| Q2 24 | $13.5M | $6.9M | ||
| Q1 24 | $15.2M | $5.0M |
净利润
CZWI
FHTX
| Q4 25 | $4.3M | $-21.7M | ||
| Q3 25 | $3.7M | $-15.8M | ||
| Q2 25 | $3.3M | $-17.9M | ||
| Q1 25 | $3.2M | $-18.8M | ||
| Q4 24 | $2.7M | $-19.5M | ||
| Q3 24 | $3.3M | $-19.1M | ||
| Q2 24 | $3.7M | $-23.0M | ||
| Q1 24 | $4.1M | $-25.0M |
营业利润率
CZWI
FHTX
| Q4 25 | 31.0% | -258.2% | ||
| Q3 25 | 27.9% | -226.9% | ||
| Q2 25 | 25.1% | -279.2% | ||
| Q1 25 | 28.0% | -385.0% | ||
| Q4 24 | 24.5% | -840.5% | ||
| Q3 24 | 29.5% | -305.5% | ||
| Q2 24 | 35.0% | -386.6% | ||
| Q1 24 | 34.2% | -558.3% |
净利率
CZWI
FHTX
| Q4 25 | 27.1% | -234.3% | ||
| Q3 25 | 22.7% | -194.4% | ||
| Q2 25 | 20.3% | -237.3% | ||
| Q1 25 | 22.5% | -316.4% | ||
| Q4 24 | 19.7% | -682.9% | ||
| Q3 24 | 23.1% | -244.9% | ||
| Q2 24 | 27.2% | -333.6% | ||
| Q1 24 | 26.9% | -495.4% |
每股收益(稀释后)
CZWI
FHTX
| Q4 25 | $0.44 | $-0.35 | ||
| Q3 25 | $0.37 | $-0.25 | ||
| Q2 25 | $0.33 | $-0.28 | ||
| Q1 25 | $0.32 | $-0.30 | ||
| Q4 24 | $0.28 | $-0.23 | ||
| Q3 24 | $0.32 | $-0.31 | ||
| Q2 24 | $0.35 | $-0.45 | ||
| Q1 24 | $0.39 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $118.9M | $80.9M |
| 总债务越低越好 | $51.8M | — |
| 股东权益账面价值 | $187.9M | $-108.5M |
| 总资产 | $1.8B | $198.1M |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势,按日历期对齐
现金及短期投资
CZWI
FHTX
| Q4 25 | $118.9M | $80.9M | ||
| Q3 25 | $82.4M | $89.3M | ||
| Q2 25 | $67.5M | $72.6M | ||
| Q1 25 | $100.2M | $61.0M | ||
| Q4 24 | $50.2M | $55.5M | ||
| Q3 24 | $36.6M | $57.7M | ||
| Q2 24 | $36.9M | $138.9M | ||
| Q1 24 | $28.6M | $79.3M |
总债务
CZWI
FHTX
| Q4 25 | $51.8M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $66.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
CZWI
FHTX
| Q4 25 | $187.9M | $-108.5M | ||
| Q3 25 | $186.8M | $-89.7M | ||
| Q2 25 | $183.5M | $-76.7M | ||
| Q1 25 | $180.1M | $-61.7M | ||
| Q4 24 | $179.1M | $-45.5M | ||
| Q3 24 | $180.1M | $-28.3M | ||
| Q2 24 | $176.0M | $-14.3M | ||
| Q1 24 | $172.8M | $-97.5M |
总资产
CZWI
FHTX
| Q4 25 | $1.8B | $198.1M | ||
| Q3 25 | $1.7B | $205.0M | ||
| Q2 25 | $1.7B | $226.2M | ||
| Q1 25 | $1.8B | $258.7M | ||
| Q4 24 | $1.7B | $284.0M | ||
| Q3 24 | $1.8B | $308.4M | ||
| Q2 24 | $1.8B | $328.6M | ||
| Q1 24 | $1.8B | $255.0M |
负债/权益比
CZWI
FHTX
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.37× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $11.7M | $-22.3M |
| 自由现金流经营现金流 - 资本支出 | $10.4M | — |
| 自由现金流率自由现金流/营收 | 65.9% | — |
| 资本支出强度资本支出/营收 | 8.3% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.74× | — |
| 过去12个月自由现金流最近4个季度 | $17.5M | — |
8季度趋势,按日历期对齐
经营现金流
CZWI
FHTX
| Q4 25 | $11.7M | $-22.3M | ||
| Q3 25 | $6.6M | $-18.9M | ||
| Q2 25 | $-406.0K | $-21.0M | ||
| Q1 25 | $1.6M | $-24.0M | ||
| Q4 24 | $20.4M | $-24.5M | ||
| Q3 24 | $3.5M | $-21.0M | ||
| Q2 24 | $5.1M | $-25.5M | ||
| Q1 24 | $9.1M | $-29.3M |
自由现金流
CZWI
FHTX
| Q4 25 | $10.4M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $-632.0K | $-21.0M | ||
| Q1 25 | $1.5M | $-24.0M | ||
| Q4 24 | $19.5M | $-25.0M | ||
| Q3 24 | $3.4M | $-21.3M | ||
| Q2 24 | $4.8M | $-25.6M | ||
| Q1 24 | $8.9M | $-29.4M |
自由现金流率
CZWI
FHTX
| Q4 25 | 65.9% | — | ||
| Q3 25 | 38.4% | — | ||
| Q2 25 | -3.9% | -278.2% | ||
| Q1 25 | 10.7% | -403.2% | ||
| Q4 24 | 142.2% | -875.3% | ||
| Q3 24 | 23.8% | -273.0% | ||
| Q2 24 | 35.7% | -371.0% | ||
| Q1 24 | 58.9% | -583.1% |
资本支出强度
CZWI
FHTX
| Q4 25 | 8.3% | 0.0% | ||
| Q3 25 | 2.4% | 0.0% | ||
| Q2 25 | 1.4% | 0.3% | ||
| Q1 25 | 0.7% | 0.5% | ||
| Q4 24 | 6.5% | 16.8% | ||
| Q3 24 | 0.9% | 4.0% | ||
| Q2 24 | 2.3% | 0.2% | ||
| Q1 24 | 1.4% | 2.0% |
现金转化率
CZWI
FHTX
| Q4 25 | 2.74× | — | ||
| Q3 25 | 1.80× | — | ||
| Q2 25 | -0.12× | — | ||
| Q1 25 | 0.50× | — | ||
| Q4 24 | 7.55× | — | ||
| Q3 24 | 1.07× | — | ||
| Q2 24 | 1.39× | — | ||
| Q1 24 | 2.24× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图